696 related articles for article (PubMed ID: 26639396)
1. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
[TBL] [Abstract][Full Text] [Related]
2. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
4. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.
Silva PE; Fayad L; Lazzarotto C; Ronsoni MF; Bazzo ML; Colombo BS; Dantas-Correa EB; Narciso-Schiavon JL; Schiavon LL
Liver Int; 2015 May; 35(5):1516-23. PubMed ID: 24840673
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
[TBL] [Abstract][Full Text] [Related]
6. No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
Kimer N; Gudmann NS; Pedersen JS; Møller S; Nielsen MJ; Leeming DJ; Karsdal MA; Møller HJ; Bendtsen F; Grønbæk H
PLoS One; 2018; 13(9):e0203200. PubMed ID: 30183743
[TBL] [Abstract][Full Text] [Related]
7. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP
Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
Andersen ES; Rødgaard-Hansen S; Moessner B; Christensen PB; Møller HJ; Weis N
Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):117-22. PubMed ID: 24424890
[TBL] [Abstract][Full Text] [Related]
9. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.
Rainer F; Horvath A; Sandahl TD; Leber B; Schmerboeck B; Blesl A; Groselj-Strele A; Stauber RE; Fickert P; Stiegler P; Møller HJ; Grønbaek H; Stadlbauer V
Aliment Pharmacol Ther; 2018 Mar; 47(5):657-664. PubMed ID: 29266346
[TBL] [Abstract][Full Text] [Related]
12. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
[TBL] [Abstract][Full Text] [Related]
13. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure.
Li TP; Guan SH; Wang Q; Chen LW; Yang K; Zhang H
World J Gastroenterol; 2019 Oct; 25(37):5667-5675. PubMed ID: 31602166
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.
Jalan R; Saliba F; Pavesi M; Amoros A; Moreau R; Ginès P; Levesque E; Durand F; Angeli P; Caraceni P; Hopf C; Alessandria C; Rodriguez E; Solis-Muñoz P; Laleman W; Trebicka J; Zeuzem S; Gustot T; Mookerjee R; Elkrief L; Soriano G; Cordoba J; Morando F; Gerbes A; Agarwal B; Samuel D; Bernardi M; Arroyo V;
J Hepatol; 2014 Nov; 61(5):1038-47. PubMed ID: 24950482
[TBL] [Abstract][Full Text] [Related]
15. Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose.
Siggaard CB; Kazankov K; Rødgaard-Hansen S; Møller HJ; Donnelly MC; Simpson KJ; Grønbaek H
Scand J Gastroenterol; 2019 May; 54(5):623-632. PubMed ID: 31067143
[TBL] [Abstract][Full Text] [Related]
16. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.
Jalan R; Pavesi M; Saliba F; Amorós A; Fernandez J; Holland-Fischer P; Sawhney R; Mookerjee R; Caraceni P; Moreau R; Ginès P; Durand F; Angeli P; Alessandria C; Laleman W; Trebicka J; Samuel D; Zeuzem S; Gustot T; Gerbes AL; Wendon J; Bernardi M; Arroyo V;
J Hepatol; 2015 Apr; 62(4):831-40. PubMed ID: 25463539
[TBL] [Abstract][Full Text] [Related]
17. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.
Dhiman RK; Agrawal S; Gupta T; Duseja A; Chawla Y
World J Gastroenterol; 2014 Oct; 20(40):14934-41. PubMed ID: 25356054
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
Li H; Chen LY; Zhang NN; Li ST; Zeng B; Pavesi M; Amorós À; Mookerjee RP; Xia Q; Xue F; Ma X; Hua J; Sheng L; Qiu DK; Xie Q; Foster GR; Dusheiko G; Moreau R; Gines P; Arroyo V; Jalan R
Sci Rep; 2016 May; 6():25487. PubMed ID: 27146801
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.
Bossen L; Rebora P; Bernuzzi F; Jepsen P; Gerussi A; Andreone P; Galli A; Terziroli B; Alvaro D; Labbadia G; Aloise C; Baiocchi L; Giannini E; Abenavoli L; Toniutto P; Marra F; Marzioni M; Niro G; Floreani A; Møller HJ; Valsecchi MG; Carbone M; Grønbaek H; Invernizzi P
Liver Int; 2020 Jun; 40(6):1408-1414. PubMed ID: 32279422
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure.
Nielsen MC; Hvidbjerg Gantzel R; Clària J; Trebicka J; Møller HJ; Grønbæk H
Cells; 2020 May; 9(5):. PubMed ID: 32397365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
